BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 36226479)

  • 1. The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands.
    de la Court F; Boyd A; Coyer L; van den Elshout M; de Vries HJC; Matser A; Hoornenborg E; Prins M;
    HIV Med; 2023 Feb; 24(2):212-223. PubMed ID: 36226479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    van den Elshout MAM; Wijstma ES; Boyd A; Jongen VW; Coyer L; Anderson PL; Davidovich U; de Vries HJC; Prins M; Schim van der Loeff MF; Hoornenborg E;
    PLoS Med; 2024 May; 21(5):e1004328. PubMed ID: 38718068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.
    Coyer L; Prins M; Davidovich U; van Bilsen WPH; Schim van der Loeff MF; Hoornenborg E; Matser A; Boyd A
    AIDS Patient Care STDS; 2022 Jun; 36(6):208-218. PubMed ID: 35687814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: Results from a prospective observational study in Germany.
    Uhrmacher M; Skaletz-Rorowski A; Nambiar S; Schmidt AJ; Ahaus P; Serova K; Mordhorst I; Kayser A; Wach J; Tiemann C; Münstermann D; Brockmeyer NH; Potthoff A
    Front Public Health; 2022; 10():930208. PubMed ID: 36091531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual behaviour, STI and HIV testing and testing need among gay, bisexual and other men who have sex with men recruited for online surveys pre/post-COVID-19 restrictions in the UK.
    Brown JR; Reid D; Howarth AR; Mohammed H; Saunders J; Pulford CV; Ogaz D; Hughes G; Mercer CH
    Sex Transm Infect; 2023 Nov; 99(7):467-473. PubMed ID: 36858811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 restrictions and changing sexual behaviours in HIV-negative MSM at high risk of HIV infection in London, UK.
    Hyndman I; Nugent D; Whitlock GG; McOwan A; Girometti N
    Sex Transm Infect; 2021 Nov; 97(7):521-524. PubMed ID: 33462118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
    Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K;
    Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men.
    van Wees DA; Diexer S; Rozhnova G; Matser A; den Daas C; Heijne J; Kretzschmar M
    Sex Transm Infect; 2022 Sep; 98(6):395-400. PubMed ID: 34716228
    [No Abstract]   [Full Text] [Related]  

  • 10. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Changes in Preexposure Prophylaxis Use and Daily Sexual Behavior After the Implementation of COVID-19 Restrictions Among Men Who Have Sex With Men.
    Jongen VW; Zimmermann HML; Boyd A; Hoornenborg E; van den Elshout MAM; Davidovich U; van Duijnhoven YTHP; de Vries HJC; Prins M; Schim van der Loeff MF; Coyer L;
    J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1111-1118. PubMed ID: 34229327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men.
    Hart TA; Noor SW; Berlin GW; Skakoon-Sparling S; Tavangar F; Tan D; Lambert G; Grace D; Lachowsky NJ; Jollimore J; Sang J; Parlette A; Lal A; Apelian H; Moore D; Cox J;
    Sex Transm Infect; 2023 May; 99(3):167-172. PubMed ID: 35701145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men.
    Jongen VW; Reyniers T; Ypma ZM; Schim van der Loeff MF; Davidovich U; Zimmermann HM; Coyer L; van den Elshout MA; de Vries HJ; Wouters K; Smekens T; Vuylsteke B; Prins M; Laga M; Hoornenborg E
    J Int AIDS Soc; 2021 Aug; 24(8):e25768. PubMed ID: 34382345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility criteria
    de la Court F; Boyd A; Davidovich U; Hoornenborg E; Schim Van Der Loeff MF; De Vries HJC; Van Wees DA; Van Benthem BHB; Xiridou M; Matser A; Prins M
    Epidemiol Infect; 2022 Nov; 150():e190. PubMed ID: 36440637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study.
    Jongen VW; Zimmermann HML; Goedhart M; Bogaards JA; Davidovich U; Coyer L; de Vries HJC; Prins M; Hoornenborg E; Schim van der Loeff MF;
    Sex Transm Infect; 2023 May; 99(3):149-155. PubMed ID: 35584898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Sexually Transmitted Infections After Initiating HIV Pre-Exposure Prophylaxis Among MSM in Southern Denmark.
    Azarnoosh M; Johansen IS; Martin-Iguacel R
    Am J Mens Health; 2021; 15(3):15579883211018917. PubMed ID: 34036826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis.
    Songtaweesin WN; Pornpaisalsakul K; Kawichai S; Wacharachaisurapol N; Wongharn P; Yodkitudomying C; Panichnantakul P; Theerawit T; Pankam T; Puthanakit T
    Int J STD AIDS; 2022 Apr; 33(5):447-455. PubMed ID: 35282719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrEP Use and Persistence Among Young Sexual Minority Men 17-24 Years Old During the COVID-19 Pandemic.
    Hong C; Horvath KJ; Stephenson R; Nelson KM; Petroll AE; Walsh JL; John SA
    AIDS Behav; 2022 Mar; 26(3):631-638. PubMed ID: 34387777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
    McManus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; McNulty A; Smith D; Guy R
    JAMA Netw Open; 2020 Dec; 3(12):e2030806. PubMed ID: 33355675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.